ProfileGDS5678 / 1451101_a_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 114.2196100
GSM967853U87-EV human glioblastoma xenograft - Control 214.1953100
GSM967854U87-EV human glioblastoma xenograft - Control 314.1407100
GSM967855U87-EV human glioblastoma xenograft - Control 414.543100
GSM967856U87-EV human glioblastoma xenograft - Control 514.3543100
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 113.977100
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 214.1217100
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 314.4849100
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 414.5793100
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 114.3373100
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 214.2242100
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 314.4648100
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 414.2518100
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 514.3676100